TeloB-VAX

N/A

Report date: 2022/03/08 17:31:05

Base Information

Drug NameTeloB-VAX
Drug Alias NameB-cell vaccine - AdamisB-lymphocyte vaccine - Adamis
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulantsTelomerase reverse transcriptase activators
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSan Diego
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSan DiegoAdamis Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A